Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10569 | 1052 | 45.2 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
1655 | 2 | BIOSIMILAR//FCRN//PROTEIN FORMULATION | 6878 |
10569 | 1 | FCRN//NEONATAL FC RECEPTOR//TARGET MEDIATED DRUG DISPOSITION | 1052 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FCRN | authKW | 2889670 | 12% | 78% | 127 |
2 | NEONATAL FC RECEPTOR | authKW | 1394597 | 6% | 78% | 62 |
3 | TARGET MEDIATED DRUG DISPOSITION | authKW | 625871 | 3% | 74% | 29 |
4 | NEONATAL FC RECEPTOR FCRN | authKW | 520282 | 2% | 81% | 22 |
5 | ROSENSTIEL BASIC BIOMED SCI | address | 232188 | 1% | 67% | 12 |
6 | FCGRT | authKW | 206394 | 1% | 89% | 8 |
7 | PHARMACOKINET PHARMACODYNAM SCI | address | 158242 | 2% | 32% | 17 |
8 | IGG CATABOLISM | authKW | 158019 | 1% | 78% | 7 |
9 | TMDD | authKW | 154792 | 1% | 67% | 8 |
10 | ANTIBODY PHARMACOKINETICS | authKW | 149267 | 1% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 3139 | 27% | 0% | 285 |
2 | Pharmacology & Pharmacy | 2687 | 31% | 0% | 323 |
3 | Medicine, Research & Experimental | 518 | 9% | 0% | 98 |
4 | Reproductive Biology | 407 | 4% | 0% | 44 |
5 | Biochemistry & Molecular Biology | 156 | 15% | 0% | 153 |
6 | Cell Biology | 91 | 7% | 0% | 72 |
7 | Developmental Biology | 60 | 2% | 0% | 20 |
8 | Biochemical Research Methods | 52 | 3% | 0% | 35 |
9 | Chemistry, Medicinal | 51 | 3% | 0% | 30 |
10 | Chemistry, Multidisciplinary | 35 | 7% | 0% | 74 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ROSENSTIEL BASIC BIOMED SCI | 232188 | 1% | 67% | 12 |
2 | PHARMACOKINET PHARMACODYNAM SCI | 158242 | 2% | 32% | 17 |
3 | DRUG DISPOSIT DEV COMMERCIALIZAT | 74627 | 1% | 43% | 6 |
4 | WM KECK CELLULAR VISUALIZAT | 69091 | 1% | 24% | 10 |
5 | DAVIS HEART LUNG 012K | 65304 | 0% | 75% | 3 |
6 | CLIN PHARMACOL ONCOL BUSINESS UNIT | 58049 | 0% | 100% | 2 |
7 | DAVIS HEART LUNG 425 | 58049 | 0% | 100% | 2 |
8 | LARGE MOL BIOANALYT DEV | 58049 | 0% | 100% | 2 |
9 | ROSENTIEL BASIC BIOMED SCI | 58049 | 0% | 100% | 2 |
10 | TRANSLAT MODELING SIMULAT | 58049 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MABS | 128020 | 5% | 8% | 57 |
2 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 63905 | 3% | 6% | 36 |
3 | AAPS JOURNAL | 24623 | 3% | 3% | 31 |
4 | PHARMACEUTICAL RESEARCH | 4657 | 3% | 0% | 36 |
5 | PROTEIN ENGINEERING DESIGN & SELECTION | 2776 | 1% | 1% | 10 |
6 | CLINICAL PHARMACOKINETICS | 2062 | 1% | 1% | 13 |
7 | JOURNAL OF CLINICAL PHARMACOLOGY | 1899 | 2% | 0% | 19 |
8 | JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 1751 | 1% | 1% | 11 |
9 | PLACENTA | 1642 | 1% | 0% | 15 |
10 | DRUG METABOLISM AND PHARMACOKINETICS | 1437 | 1% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FCRN | 2889670 | 12% | 78% | 127 | Search FCRN | Search FCRN |
2 | NEONATAL FC RECEPTOR | 1394597 | 6% | 78% | 62 | Search NEONATAL+FC+RECEPTOR | Search NEONATAL+FC+RECEPTOR |
3 | TARGET MEDIATED DRUG DISPOSITION | 625871 | 3% | 74% | 29 | Search TARGET+MEDIATED+DRUG+DISPOSITION | Search TARGET+MEDIATED+DRUG+DISPOSITION |
4 | NEONATAL FC RECEPTOR FCRN | 520282 | 2% | 81% | 22 | Search NEONATAL+FC+RECEPTOR+FCRN | Search NEONATAL+FC+RECEPTOR+FCRN |
5 | FCGRT | 206394 | 1% | 89% | 8 | Search FCGRT | Search FCGRT |
6 | IGG CATABOLISM | 158019 | 1% | 78% | 7 | Search IGG+CATABOLISM | Search IGG+CATABOLISM |
7 | TMDD | 154792 | 1% | 67% | 8 | Search TMDD | Search TMDD |
8 | ANTIBODY PHARMACOKINETICS | 149267 | 1% | 86% | 6 | Search ANTIBODY+PHARMACOKINETICS | Search ANTIBODY+PHARMACOKINETICS |
9 | IGG TRANSPORT | 116094 | 1% | 67% | 6 | Search IGG+TRANSPORT | Search IGG+TRANSPORT |
10 | SERUM HALF LIFE | 97946 | 1% | 38% | 9 | Search SERUM+HALF+LIFE | Search SERUM+HALF+LIFE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GIRAGOSSIAN, C , CLARK, T , PICHE-NICHOLAS, N , BOWMAN, CJ , (2013) NEONATAL FC RECEPTOR AND ITS ROLE IN THE ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF IMMUNOGLOBULIN G-BASED BIOTHERAPEUTICS.CURRENT DRUG METABOLISM. VOL. 14. ISSUE 7. P. 764-790 | 191 | 62% | 14 |
2 | SOCKOLOSKY, JT , SZOKA, FC , (2015) THE NEONATAL FC RECEPTOR, FCRN, AS A TARGET FOR DRUG DELIVERY AND THERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 91. ISSUE . P. 109 -124 | 125 | 79% | 13 |
3 | WARD, ES , DEVANABOYINA, SC , OBER, RJ , (2015) TARGETING FCRN FOR THE MODULATION OF ANTIBODY DYNAMICS.MOLECULAR IMMUNOLOGY. VOL. 67. ISSUE 2. P. 131 -141 | 112 | 80% | 8 |
4 | ROOPENIAN, DC , AKILESH, S , (2007) FCRN: THE NEONATAL FC RECEPTOR COMES OF AGE.NATURE REVIEWS IMMUNOLOGY. VOL. 7. ISSUE 9. P. 715 -725 | 72 | 84% | 676 |
5 | MARTINS, JP , KENNEDY, PJ , SANTOS, HA , BARRIAS, C , SARMENTO, B , (2016) A COMPREHENSIVE REVIEW OF THE NEONATAL FC RECEPTOR AND ITS APPLICATION IN DRUG DELIVERY.PHARMACOLOGY & THERAPEUTICS. VOL. 161. ISSUE . P. 22 -39 | 134 | 65% | 1 |
6 | KUO, TT , BAKER, K , YOSHIDA, M , QIAO, SW , AVESON, VG , LENCER, WI , BLUMBERG, RS , (2010) NEONATAL FC RECEPTOR: FROM IMMUNITY TO THERAPEUTICS.JOURNAL OF CLINICAL IMMUNOLOGY. VOL. 30. ISSUE 6. P. 777 -789 | 95 | 86% | 88 |
7 | RATH, T , KUO, TT , BAKER, K , QIAO, SW , KOBAYASHI, K , YOSHIDA, M , ROOPENIAN, D , FIEBIGER, E , LENCER, WI , BLUMBERG, RS , (2013) THE IMMUNOLOGIC FUNCTIONS OF THE NEONATAL FC RECEPTOR FOR IGG.JOURNAL OF CLINICAL IMMUNOLOGY. VOL. 33. ISSUE . P. S9-S17 | 74 | 90% | 37 |
8 | SAND, KMK , BERN, M , NILSEN, J , NOORDZIJ, HT , SANDLIE, I , ANDERSEN, JT , (2015) UNRAVELING THE INTERACTION BETWEEN FCRN AND ALBUMIN: OPPORTUNITIES FOR DESIGN OF ALBUMIN-BASED THERAPEUTICS.FRONTIERS IN IMMUNOLOGY. VOL. 5. ISSUE . P. 1 -21 | 124 | 55% | 6 |
9 | PYZIK, M , RATH, T , LENCER, WI , BAKER, K , BLUMBERG, RS , (2015) FCRN: THE ARCHITECT BEHIND THE IMMUNE AND NONIMMUNE FUNCTIONS OF IGG AND ALBUMIN.JOURNAL OF IMMUNOLOGY. VOL. 194. ISSUE 10. P. 4595 -4603 | 78 | 76% | 13 |
10 | WARD, ES , OBER, RJ , (2009) MULTITASKING BY EXPLOITATION OF INTRACELLULAR TRANSPORT FUNCTIONS: THE MANY FACES OF FCRN.ADVANCES IN IMMUNOLOGY, VOL 103. VOL. 103. ISSUE . P. 77-115 | 112 | 65% | 54 |
Classes with closest relation at Level 1 |